DISEASE AND DRUG FAMILY INFORMATION
Search results below include Disease and Drug Family Information where your selected drug
is a secondary subject of discussion.
In the other chapters of this book, we have had access to published articles describing randomized, controlled trials in medical journals, medical textbooks, the FDA-approved label, and, importantly, the detailed review of the drug (based on a review of the raw data from the sponsor’s clinical trials) conducted by the FDA medical officer, at least for more recent drugs. This evidence base is far from complete for any dietary supplement. By definition, no supplement has passed an FDA safety and efficacy review (otherwise it would be a drug).
DRUG AND DIETARY SUPPLEMENT PROFILES
A comprehensive review of the safety and effectiveness of this drug. If the drug is not a Do
Not Use product, information on adverse effects, drug interactions and how to use the
medication are included.
Search results below include Drug and Dietary Supplement Profiles where your selected
drug is a secondary subject of discussion.
-
We list this drug as a Do Not Use drug because it causes very limited weight loss and also causes high blood pressure and increased heart rate.
WORST PILLS, BEST PILLS NEWSLETTER ARTICLES
Search results below include Worst Pills, Best Pills Newsletter Articles where your
selected drug is a secondary subject of discussion.
September 2003
Canadian drug regulatory authorities reviewed reported cases of serotonin syndrome in the July 2003 issue of the Canadian Adverse Reaction Newsletter. The serotonin syndrome is a potentially life-threatening adverse drug reaction involving an excess of serotonin, a naturally occurring nerve transmitter.
ADDITIONAL INFORMATION FROM PUBLIC CITIZEN
Search results below include Additional Information from Public Citizen where your
selected drug is a secondary subject of discussion.